PHIA Koninklijke Philips N.V.

Philips and Flevo Hospital sign long-term strategic partnership agreement enabling continuous innovation and optimization of patient care

Philips and Flevo Hospital sign long-term strategic partnership agreement enabling continuous innovation and optimization of patient care



July 14, 2020

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Flevo Hospital today announced they have signed a 10-year strategic partnership agreement to continuously innovate and optimize patient care in the Almere region of the Netherlands.

The collaboration has four strategic priorities: 1) Achieving the strategic objective of 'the right care in the right place' by means of innovations and the optimal use of (medical) technology; 2) Modernizing care and strengthening communication between Flevo Hospital and its patients and partners; 3) Increasing the enthusiasm and involvement of hospital employees by unburdening care professionals and modernizing work processes; and 4) Saving costs and improving the efficiency of technology.

“We are confronted with many new challenges, but want to keep providing a high standard of affordable care not only within the hospital but also increasingly outside the hospital,” said Anita Arts, CEO of Flevo Hospital, Almere, the Netherlands. “We want to involve our patients even more closely in their care. This is possible with the help of technological solutions. Philips is a partner for the future with whom we want to innovate and develop new solutions for our strategic challenges.”

“Thanks to our broad portfolio, we can help Flevo Hospital achieve its ambitions and overcome the challenges it faces,” said Henk Valk, CEO at Philips Benelux. “In this collaboration, we will work as partners to realize a future-proof hospital. Innovation is the most important part, but good education, together with the maintenance and service of our technology, are also enormously important for the Flevo Hospital to be able to deliver high-quality patient care. In every way, we can strengthen each other and help to improve care, making cooperations like this crucial now and into the future.”

During the term of the contract, Philips will act as the preferred supplier of imaging systems, such as MR, CT and ultrasound, and patient monitoring systems. The purchase of equipment is organized through a multi-year medical technology plan to reduce costs for the hospital and make it more transparent. Flevo Hospital will gain early insight into new Philips solutions to ensure that the right equipment is purchased at the right time. The ambition of Flevo Hospital is to be able to quickly use new innovative Philips solutions to optimize workflows, patient pathways and patient experiences while driving efficiencies and cost optimization.

Under the agreement, Philips and Flevo Hospital will also work on innovation programs aimed at introducing innovative technologies and ensuring their optimal use, such as expanding patient monitoring in the hospital, as well as facilitating care outside the hospital. Another goal focuses on further enhancing the staff experience to foster passionate and committed employees. Each year, an education plan will be agreed on for the development and education of healthcare providers and medical technicians in the hospital, so that Philips' technology can be used optimally and efficiently for patient care.

For further information, please contact:

Joost Maltha

Philips Global Press Office

Tel.: 16

E-mail:

Pieter de Meer

Philips Benelux

Tel.: 65

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachment

EN
14/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch